Impact TB co-infections on immune tolerance among people living with HIV: a systematic review

References

• GLOBAL AIDS RESPONSE PROGRESS REPORTING 2014 Construction of Core Indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS,” 2014.
   Google Scholar
• UNAIDS, GLOBAL REPORT on HIV/AIDS response, 2013.
   Google Scholar
• Naomi FW, Graeme M, Robert JW. HIV-1 and the immune response to TB. Future Virol. 2013;8(1):57–80.
   PubMed Web of Science ®Google Scholar
• Billong SC, Ayong APR, Koulla-Shiro S. Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central hospital, Cameroon : an 8-year retrospective cohort study (2006–2013). 2015;1–13.
   Google Scholar
• Chang CC. HIV and co-infections. Immunol Rev. 2014;254(1):114–142.
   Google Scholar
• Apidechkul T. A 20-year retrospective cohort study of TB infection among the hill-tribe HIV/AIDS populations, Thailand. BMC Infect Dis. 2015;16(1):1–14.
   Google Scholar
• Balcha TT, Jemal ZH, Tibesso G, et al. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia. PLoS One. 2013;8(12):e83270.
   PubMed Web of Science ®Google Scholar
• Bell LCK. In vivo molecular dissection of the effects of HIV-1 in active tuberculosis. 2016;1–25.
   Google Scholar
• Mokondjimobe E, Longo-Mbenza B, Mampouya-Arrouse P, et al. Inflammatory status hepatic enzymes and serum creatinine in HIV -, HIV + and HIV-TB co-infected adult Central Africans. Int J Gen Med. 2012;5:961–965.
   PubMedGoogle Scholar
• Ashwin B, et al. Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients. 2015;60(2):477–486.
   Google Scholar
• Global update on HIV treatment. 2013: results, impact and opportunities. 2013.
   Google Scholar
• Pollock KM, et al. PD-1 expression and cytokine secretion profiles of mycobacterium tuberculosis - specific CD4 + T-cell subsets; potential correlates of containment in HIV-TB co- infection. 2016;1–15.
   Google Scholar
• Shao L, Zhang X, Gao Y, et al. Hierarchy low CD4 +/CD8 + T-Cell counts and IFN- γ responses in HIV-1 + individuals correlate with active TB and/or M. TB co- infection. 1. PLoS One. 2016;11(3):e0150941–e01509412.
   PubMed Web of Science ®Google Scholar
• Tomlinson GS, Bell LCK, Walker NF, et al. HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. J Infect Dis. 2014;209(7):1055–1065.
   PubMed Web of Science ®Google Scholar
• Reepalu A, Balcha TT, Skogmar S, et al. High rates of virological suppression in a cohort of human immunodeficiency virus- positive adults receiving antiretroviral therapy in Ethiopian health centers irrespective of concomitant tuberculosis. 2014;1–8.
   Google Scholar
• Eihott AM, et al. Eosinophilia and progression to active tuberculosis in HIV-l-infected Ugandans. 2003;477–480.
   Google Scholar
• Friedland G, Churchyard GJ, Nardell E. Tuberculosis and HIV coinfection : Current state of knowledge and research priorities. 2007;196(Suppl 1):3–5.
   Google Scholar
• Onyebujoh PC, Ribeiro I, Whalen CC. Treatment options for HIV-associated tuberculosis. 2007;35–45.
   Google Scholar
• Ticona E, Huaman MA, Yanque O, et al. NIH public access. J Int Assoc Provid AIDS Care. 2013;12(6):373–374.
   PubMedGoogle Scholar
• Moore D, et al. Prevalence, incidence and mortality associated with tuberculosis in PLHIV initiating antiretroviral therapy in rural Uganda. August 2006, 2007.
   Google Scholar
• Dean GL, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16(1):75–83.
   PubMed Web of Science ®Google Scholar
• Hu Y, et al. NIH public access. 2013;64(1):103–114.
   Google Scholar
• Freeman ML, Lederman MM, Gianella S, et al. HHS public access. Curr HIV/AIDS Rep. 2016;13(1):10–19.
   PubMedGoogle Scholar
• Hernando V, et al. Overall and cause-specific excess mortality in HIV-positive persons compared with the general population. Medicine (Baltimore). 2016;95(36):e4727.
   PubMed Web of Science ®Google Scholar
• Muazu M, Nimzing L, Idoko J, et al. NIH public access. J Acquir Immune Defic Syndr. 2013;62(2):204–207.
   PubMedGoogle Scholar
• Reepalu A, Balcha TT, Skogmar S, et al. Factors associated with early mortality in HIV-Positive men and women investigated for tuberculosis at Ethiopian health centers. 2016;1–13.
   Google Scholar
• Skied DJ, Keiser P. Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians’ beliefs, practices, and knowledge. Arch Fam Med. 1997;6(3):289–294. doi: 10.1001/archfami.6.3.289. PMID: 9161358.
   PubMedGoogle Scholar
• Read J. On the occurrence of eosinophilia in tuberculosis treated with antibiotics: a preliminary observation. British J Tuberculosis Diseases Chest. 1954;34–38.
   Google Scholar
• Idemyor V. HIV and tuberculosis coinfection: inextricably linked liaison. J Natl Med Assoc. 2007;99(12):1414–1419. PMID: 18229780; PMCID: PMC2575925.
   PubMed Web of Science ®Google Scholar
• Matthews K, Ntsekhe M, Syed F, et al. HIV-1 infection alters CD4 1 memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. Eur J Immunol. 2012;42(1):147–157.
   PubMed Web of Science ®Google Scholar
• Zahra T. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis. 2003;88(8):1146–1155.
   Google Scholar
• Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis : clinical update. Clinical Infectious Dis. 2010;50:1377–1386.
   PubMed Web of Science ®Google Scholar
• Charles M, Pape JW. Tuberculosis and HIV: Implications in the developing world. Curr HIV/AIDS Rep. 2006;3(3):139–144. doi: 10.1007/BF02696658. PMID: 16970841.
   PubMedGoogle Scholar